Eric Topol/X;
Leslie Skeith/ucalgary.ca; Shannon M. Bates/fwgbd.org
Apr 17, 2026, 14:34
Eric Topol: The Role of Sex Hormones in Venous Thromboembolism and Cardiovascular Disease Risk
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared a post on X about a recent article by Leslie Skeith, published in NEJM:
“Sex hormones, clotting disorders, and cardiovascular risk – An important new NEJM review for MHT and testosterone latest data.”
Title: Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk
Authors: Leslie Skeith, Shannon M. Bates
Other posts featuring Eric Topol on Hemostasis Today.
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A